Table 1. Leaders in the number of public-private partnerships. U.S. institutes were involved in over half of the reported public-private partnerships (PPPs) in 2011, with such institutes taking four of the five top spots in terms of the number of deals done. Although U.S. companies were involved in about half of the reported PPPs in 2011, France's Sanofi was by far the most active single company. Excludes deals that only involve IP transfer.

Source: BioCentury Archives

Institute

Number of PPPs

University of California (UCSF/UCSD/UCD/UCLA)

10

NIH (includes NCI/NHGRI/NIAID)

7

Columbia University

6

Harvard University

6

BGI (formerly the Beijing Genomics Institute)

5

Company

Number of PPPs

Sanofi (Euronext:SAN; NYSE:SNY)

12

AstraZeneca plc (LSE:AZN; NYSE:AZN)

9

Pfizer Inc. (NYSE:PFE)

9

Roche (SIX:ROG; OTCQX:RHHBY)

9

Johnson & Johnson (NYSE:JNJ)

6

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK)

6